The long history of underground drug use abounds with secret societies—colorful cliques of like-minded individuals surreptitiously experimenting with newfangled compounds in an effort to understand their mysteries. Mid-19th-century France saw artists and intellectuals like Baudelaire and Dumas gathered at the Club of the Hash Eaters to partake of the powerful sticky cannabis concentrate. It’s a weight-loss injectable, like semaglutide (marketed as Wegovy) or tirzepatide (marketed as Zepbound). But the key difference with this weight-loss drug, besides the pesky matter of its legality, is that it appears to be much, much more powerful than those approved so far. (He left the company in 2003, in part because he felt the company didn’t then prioritize obesity treatments or see the benefit of an injectable weight-loss drug.)